Nuzenio

Tradingview Hrtx

Tradingview Hrtx entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 6 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 13:32:09 GMTHRTX: Q2 net revenue grew to $37.7M, but guidance was withdrawn due to CINVANTI patent uncertainty - TradingView
Mon, 10 Aug 2026 12:16:13 GMTHRTX: Acute care sales surged, oncology declined, and net loss widened amid ongoing strategic review - TradingView
Mon, 10 Aug 2026 12:03:01 GMTHeron Therapeutics reports Q2 2026 revenue $37.7M, withdraws 2026 guidance after patent ruling - TradingView
Fri, 07 Aug 2026 17:00:07 GMTHeron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview - TradingView
Fri, 07 Aug 2026 11:00:26 GMTHRTX Q2'26 Earnings: EPS estimate is (0.01) USD - TradingView
Sat, 01 Aug 2026 05:02:16 GMTHeron Therapeutics, Inc. Revenue Breakdown – NASDAQ:HRTX - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Hrtx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.